EGFR and paronychia: Paronychia (painful inflammation of the nail fold) and periungual pyogenic-like lesions are the frequent adverse reaction to EGFR inhibitors, appearing after one or two months of treatment in 10-15% of the patients [27] due to the direct inhibition of keratinocytes in the nail matrix [19].